Evidence check: FT4 in the context of gut health

The link between free thyroxine (FT4) and gut health is an area of emerging research but remains mechanistically plausible rather than clinically proven. The gut microbiome can influence thyroid hormone metabolism through effects on inflammation, nutrient absorption (e.g., iodine, selenium), and enterohepatic circulation. Conversely, thyroid hormones may modulate gut motility and barrier function. However, most evidence comes from animal models or small observational human studies; large-scale interventional trials are lacking. A single FT4 measurement from a consumer test cannot reliably assess gut health or diagnose thyroid dysfunction. FT4 levels fluctuate diurnally and are affected by medications, diet, and stress. For a comprehensive evaluation, clinical assessment including TSH, fT3, thyroid antibodies, and possibly gut markers (e.g., calprotectin, microbiome analysis) is required. Consumers should be cautious: marketing often overstates the gut–thyroid connection. Evidence grade: mechanistic. No direct human-strong studies confirm FT4 as a gut health biomarker.